Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 1;20(19):5749-52.
doi: 10.1016/j.bmcl.2010.08.001. Epub 2010 Aug 5.

Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A

Affiliations

Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A

David Y W Lee et al. Bioorg Med Chem Lett. .

Abstract

Salvinorin A (1), the main active ingredient of Salvia divinorum, is a potent and selective κ opioid receptor (KOPR) agonist. Based on the SAR, its C-2 position is one of the key binding sites and has very little space tolerance (3-4 carbons atoms) and limited to only lipophilic groups. In our attempt to prepare PET brain imaging agent for mapping KOPR, a series of C-2 halogenated analogs have been synthesized and screened for binding affinity at κ (KOPR), μ (MOPR), and δ (DOPR). These C-2 halogenated analogs with sequential changes of atomic radius and electron density serve as excellent molecular probes for further investigating the binding pocket at C-2, particularly on the effects of α verses β configuration at C-2 position. The results of KOPR binding and functional studies reveal β isomer in general binds better than α isomer with the exception of iodinated analogs and none of the C-2 halogenated analogs shows any improvement of KOPR binding affinity. Interestingly, functional assay has characterized that 6b is a partial agonist with E(max) of 46% of the kappa receptor full agonist U50,488H at 250 nM (K(i)). We have also observed that the affinity to the kappa receptor increases with atomic radius (I>Br>Cl>F) which is in good agreement with halogen bonding interactions reported in the literature.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Scheme 1
Scheme 1
Reagents and conditions: (a) Deoxo-Fluor reagent, CH2Cl2, −78 °C, 2 h, rt, 2 h, 3b (74%), 3a (80%); (b) TCT, DMF/CH2Cl2, 35 °C, 12 h, 4b (90%), 4a (81%); (c) TCT,DMF/CH2Cl2, rt, 2 h; yield varies according to reaction time.
Scheme 2
Scheme 2
Reagents and conditions: (a) TCT, DMF/CH2Cl2, NaBr, overnight, 92%, 4b:5b = 3:2; (b) PBr3, C6H6, rt, 86%; (c) PPh3, Br2, imidazole, toluene, 48%; (d) (i) (CF3SO2)2O, pyridine, CH2Cl2, 0 °C; (ii) NaBr, DMF, rt, 75% in two-steps.
Scheme 3
Scheme 3
Reagents and conditions: (a) I2, PPh3, imidazole, Toluene, 80 °C, 1 h, 92–95%; (b) LiI, DMF, rt, overnight, 95%.

Similar articles

Cited by

References

    1. Siebert DJ. J. Ethnopharmacol. 1994;43:53. - PubMed
    1. Butelman ER, Prisinzano TE, Deng H, Rus S, Kreek MJ. J. Pharmacol. Exp. Ther. 2009;328:588. - PMC - PubMed
    1. Harding WW, Tidgewell K, Schmidt M, Shah K, Dersch CM, Snyder J, Parrish D, Deschamps JR, Rothman RB, Prisinzano TE. Org. Lett. 2005;7:3017. - PMC - PubMed
    1. González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ. Drug Alcohol Depend. 2006;85:157. - PubMed
    1. Ortega A, Blount JF, Manchand PS. J. Chem. Soc. Perkin Trans. 1. 1982:2505.

Publication types

LinkOut - more resources